NCT03206944View on ClinicalTrials.gov

Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

January 1, 2017

Study Completion Date

June 1, 2017

Conditions
Hypertension,EssentialObesity
Interventions
DRUG

acetylsalicylic acid

Group 1(ASA) included 33 patients who received acetylsalicylic acid at a dose of 75 mg in the morning

DRUG

Tomato Fruit Extract

Group 2 (STE) included 32 patients receiving standardized tomato extract (STE) (ZAAX, Sequia, Poland) at a dose of 213 mg orally in the morning

All Listed Sponsors
lead

Beata Krasinska

OTHER

NCT03206944 - Antiplatlet Effects of Standardized Tomato Extract in Hypertensive Subjects | Biotech Hunter | Biotech Hunter